Compare · ALGN vs HSCS
ALGN vs HSCS
Side-by-side comparison of Align Technology Inc. (ALGN) and HeartSciences Inc. (HSCS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALGN and HSCS operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ALGN is the larger of the two at $12.53B, about 2355.9x HSCS ($5.3M).
- Over the past year, ALGN is down 2.0% and HSCS is down 53.9% - ALGN leads by 51.9 points.
- ALGN has been more active in the news (16 items in the past 4 weeks vs 1 for HSCS).
- ALGN has more recent analyst coverage (25 ratings vs 0 for HSCS).
- Company
- Align Technology Inc.
- HeartSciences Inc.
- Price
- $175.01+0.98%
- $1.70-4.49%
- Market cap
- $12.53B
- $5.3M
- 1M return
- -1.99%
- -18.27%
- 1Y return
- -1.99%
- -53.93%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2001
- 2022
- News (4w)
- 16
- 1
- Recent ratings
- 25
- 0
Align Technology Inc.
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Latest ALGN
- SEC Form SD filed by Align Technology Inc.
- Director Vitalone Britt J. converted options into 1,443 shares (SEC Form 4)
- Director Siegel Susan E converted options into 1,745 shares, increasing direct ownership by 19% to 10,723 units (SEC Form 4)
- Director Saia Andrea Lynn converted options into 1,745 shares, increasing direct ownership by 11% to 17,318 units (SEC Form 4)
- Director Poul Mojdeh converted options into 1,745 shares, increasing direct ownership by 97% to 3,553 units (SEC Form 4)
- Director Myong Anne converted options into 1,745 shares, increasing direct ownership by 22% to 9,830 units (SEC Form 4)
- Director Larkin C Raymond Jr converted options into 2,326 shares, increasing direct ownership by 9% to 27,454 units (SEC Form 4)
- Director Dallas Kevin J converted options into 1,745 shares, increasing direct ownership by 12% to 16,168 units (SEC Form 4)
- Director Lacob Joseph converted options into 1,745 shares (SEC Form 4)
- Director Conroy Kevin T converted options into 1,745 shares, increasing direct ownership by 97% to 3,553 units (SEC Form 4)
Latest HSCS
- HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network
- HeartSciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™
- SEC Form QUALIF filed by HeartSciences Inc.
- SEC Form 253G2 filed by HeartSciences Inc.
- HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting
- SEC Form 1-A POS filed by HeartSciences Inc.
- HeartSciences Inc. filed SEC Form 8-K: Leadership Update
- HeartSciences' MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category
- HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings